🔎 Trials Near Me

Beranda › Leukemia Mieloid Akut › Virginia › Richmond

Uji klinis Leukemia Mieloid Akut di Richmond, VA

12 studi untuk Leukemia Mieloid Akut mencari peserta di lokasi sekitar Richmond (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.

Teks studi resmi (Bahasa Inggris)

Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Menerima pesertaStudi observasionalSukarelawan sehat diterima
  • Bon Secours Richmond Community Hospital, Richmond
  • Bon Secours Saint Mary's Hospital, Richmond
  • Bon Secours Cancer Institute at Reynolds Crossing, Richmond
  • dan 3 lainnya
Usia 40 hingga 75 · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT05334069

A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)

Menerima pesertaFase 3
  • Virginia Commonwealth University - Massey Cancer Center, Richmond
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT06852222

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

Menerima pesertaFase 2
  • VCU Massey Comprehensive Cancer Center, Richmond
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT05564390

Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)

Menerima pesertaFase 2
  • VCU Massey Comprehensive Cancer Center, Richmond
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT06317649

Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)

Menerima pesertaFase 2
  • VCU Massey Comprehensive Cancer Center, Richmond
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT06672146

Metronomic Decitabine-Cedazuridine and Venetoclax in R/R AML, HR-MDS, HR/AP MPN

Menerima pesertaFase 2
  • Virginia Commonwealth University, Richmond
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 21 Sep 2026 · NCT07710534

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

Menerima pesertaFase 3
  • VCU Massey Comprehensive Cancer Center, Richmond
6 Months – 21 Years · Semua jenis kelamin · Diperbarui 17 Sep 2026 · NCT04293562

Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)

Menerima pesertaFase 3
  • Children's Hospital of Richmond at Virginia Commonwealth University, Richmond
29 Days – 21 Years · Semua jenis kelamin · Diperbarui 24 Agu 2026 · NCT05183035

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

Menerima pesertaStudi observasional
  • Virginia Commonwealth University, Richmond
Semua usia · Semua jenis kelamin · Diperbarui 6 Jul 2026 · NCT01351545

Oral Azacitidine in Transplant-Eligible Patients With Acute Myeloid Leukemia (AML) Suffering From Health-Inequality

Menerima pesertaFase 4
  • Virginia Commonwealth University, Richmond
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 29 Mei 2026 · NCT06370000

Olutasidenib Single Plus Combo Therapy in IDH1mut AML After Induction and Consolidation

Menerima pesertaFase 1
  • Virginia Commonwealth University, Richmond
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 6 Feb 2026 · NCT07130695

Uji klinis Leukemia Mieloid Akut di kota lain

Studi lain di Richmond

Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.